• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE Back to Search Results
Model Number ZEPHYR 4.0 LP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 11/13/2023
Event Type  Death  
Event Description
The patient had an endobronchial valve procedure.The patient passed away post procedure.More information will be provided when available.
 
Event Description
Patient selected for valve therapy after pft, symptoms, perfusion scan and intra op balloon occlusion determined her to meet all criteria.Procedure performed on (b)(6) 2023 with 3 valves in rul.After procedure- no pneumothorax and complete atelectasis of the rul just as planned.Patient refused to exercise, let nurses move her and preferred to be bed bound in hospital.Therefore - she became nasal cannula dependent from basilar atelectasis and mucus impactions.Patient did not want to participate in airway clearance.Finally, she started telling team that her daughter forced her to have the valves and that she did not want the valves.The physician notes that this was not his experience in pre - procedure interviews and detailed prolonged work up.The patient claimed that she was more short of breath after procedure and she wanted valves out.This was during the time she was refusing all pt/ot and other therapies.Per the patient's wishes the valves were removed (b)(6) 2023 (i only know that the valves were removed 2 weeks after placement but the doctor did not provide the exact date) and she went to hospice where she passed away (b)(6) 2023 (again, the only info i was given was she died 2 weeks after the valves were removed while in hospice).We are unable to get the physician's perspective on the relationship of the death to the valves, but given the valves had been removed, the death is not likely to be related to the valves, but rather the poor conditioning of the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZEPHYR ENDOBRONCHIAL VALVE
Type of Device
ENDOBRONCHIAL VALVE
Manufacturer (Section D)
PULMONX CORPORATION
700 chesapeake drive
redwood city CA 94063
Manufacturer Contact
mahtab fatemi
700 chesapeake drive
redwood city, CA 94063
6504072823
MDR Report Key18307051
MDR Text Key330220566
Report Number3007797756-2023-00220
Device Sequence Number1
Product Code NJK
UDI-Device Identifier00811907030225
UDI-Public(01)00811907030225(10)506528V71(17)241117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Remedial Action Patient Monitoring
Type of Report Initial,Followup,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberZEPHYR 4.0 LP
Device Catalogue NumberEBV-TS-4.0-LP
Device Lot Number506528-V7.1
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/17/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-